Latest news releases from NIH-funded organizations

Funded Research News

Updates every hour. Last Updated: 1-Sep-2025 20:11 ET (2-Sep-2025 00:11 GMT/UTC)

2-Mar-2025

Omalizumab treats multi-food allergy better than oral immunotherapy

NIH/National Institute of Allergy and Infectious Diseases
Peer-Reviewed Publication

The high rate of allergic reactions and other intolerable side effects of oral immunotherapy in the NIH-funded trial explained the superiority of omalizumab.

Journal

Journal of Allergy and Clinical Immunology

Funder

NIH/National Institute of Allergy and Infectious Diseases